-
In-Depth Examination Of 8 Analyst Recommendations For Neurocrine Biosciences
13 Mar 2024 20:43 GMT
… Neurocrine Biosciences analyst ratings.
All You Need to Know About Neurocrine Biosciences
Neurocrine Biosciences … central nervous system and endocrine-related categories. The … for tourette syndrome.
Neurocrine Biosciences: Delving into Financials
Market …
-
Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells 3,040 Shares of Stock
09 Feb 2024 13:01 GMT
… Stock Analysis on Neurocrine Biosciences
Neurocrine Biosciences Company Profile
(Get Free Report)
Neurocrine Biosciences, Inc discovers … , develops, and markets pharmaceuticals for neurological, endocrine, and …
-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2023 Earnings Call Transcript
08 Feb 2024 14:24 GMT
… , parents, family members and endocrinologists to help the CAH community … A Session Follow Neurocrine Biosciences Inc (NASDAQ:NBIX) Follow Neurocrine Biosciences Inc (NASDAQ:NBIX … so patients, family members, and endocrinologists. Part of it is educating …
-
Oppenheimer Asset Management Inc. Has $1.79 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
07 Feb 2024 12:47 GMT
… 143.35.
Neurocrine Biosciences Company Profile
(Free Report)
Neurocrine Biosciences, Inc … discovers, develops, and markets pharmaceuticals for neurological, endocrine … 39; ratings for Neurocrine Biosciences and related companies …
-
Oppenheimer & Co. Inc. Has $1.90 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
06 Feb 2024 16:56 GMT
… Our Latest Stock Report on Neurocrine Biosciences
Neurocrine Biosciences Trading Down 0.1 % … Report)
Neurocrine Biosciences, Inc discovers, develops, and markets pharmaceuticals for neurological, endocrine, and …
-
New York State Common Retirement Fund Raises Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
03 Feb 2024 15:15 GMT
… on Neurocrine Biosciences
Insider Buying and Selling at Neurocrine Biosciences
In other Neurocrine Biosciences news … Neurocrine Biosciences
(Free Report)
Neurocrine Biosciences, Inc discovers, develops, and markets pharmaceuticals for neurological, endocrine …
-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Eiry Roberts Sells 1,457 Shares of Stock
03 Feb 2024 15:00 GMT
… of $36,030.00.
Neurocrine Biosciences Price Performance
Neurocrine Biosciences stock opened at $141 … Report)
Neurocrine Biosciences, Inc discovers, develops, and markets pharmaceuticals for neurological, endocrine, and …
-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kevin Charles Gorman Sells 2,707 Shares of Stock
03 Feb 2024 15:00 GMT
… Stock Analysis on Neurocrine Biosciences
About Neurocrine Biosciences
(Get Free Report)
Neurocrine Biosciences, Inc discovers, develops … , and markets pharmaceuticals for neurological, endocrine, and …
-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CFO Matt Abernethy Sells 1,283 Shares
03 Feb 2024 14:59 GMT
… Institutional Trading of Neurocrine Biosciences
Want More Great … NBIX
About Neurocrine Biosciences
(Get Free Report)
Neurocrine Biosciences, Inc … discovers, develops, and markets pharmaceuticals for neurological, endocrine …
-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to Post FY2028 Earnings of $14.47 Per Share, Wedbush Forecasts
01 Feb 2024 09:45 GMT
… funds.
Neurocrine Biosciences Company Profile
(Get Free Report)
Neurocrine Biosciences, … Inc discovers, develops, and markets pharmaceuticals for neurological, endocrine … 39; ratings for Neurocrine Biosciences and related companies …